Charles Schwab’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Sell |
614,761
-60,720
| -9% | -$149K | ﹤0.01% | 2758 |
|
|
2025
Q1 | $4.51M | Buy |
675,481
+19,391
| +3% | +$129K | ﹤0.01% | 2312 |
|
|
2024
Q4 | $8.25M | Buy |
656,090
+86,276
| +15% | +$1.08M | ﹤0.01% | 2101 |
|
|
2024
Q3 | $10.5M | Buy |
569,814
+20,322
| +4% | +$375K | ﹤0.01% | 2001 |
|
|
2024
Q2 | $11.8M | Buy |
549,492
+16,929
| +3% | +$364K | ﹤0.01% | 1958 |
|
|
2024
Q1 | $14.3M | Buy |
532,563
+7,111
| +1% | +$192K | ﹤0.01% | 1800 |
|
|
2023
Q4 | $15.7M | Buy |
525,452
+57,246
| +12% | +$1.72M | ﹤0.01% | 1739 |
|
|
2023
Q3 | $9.59M | Buy |
468,206
+32,836
| +8% | +$673K | ﹤0.01% | 1923 |
|
|
2023
Q2 | $8.65M | Buy |
435,370
+7,851
| +2% | +$156K | ﹤0.01% | 1974 |
|
|
2023
Q1 | $7.32M | Buy |
427,519
+5,344
| +1% | +$91.5K | ﹤0.01% | 2019 |
|
|
2022
Q4 | $8.26M | Buy |
422,175
+78,911
| +23% | +$1.54M | ﹤0.01% | 1971 |
|
|
2022
Q3 | $5.48M | Buy |
343,264
+18,657
| +6% | +$298K | ﹤0.01% | 2166 |
|
|
2022
Q2 | $4.47M | Buy |
324,607
+1,435
| +0.4% | +$19.7K | ﹤0.01% | 2236 |
|
|
2022
Q1 | $5.13M | Buy |
323,172
+13,039
| +4% | +$207K | ﹤0.01% | 2267 |
|
|
2021
Q4 | $6.77M | Buy |
310,133
+6,829
| +2% | +$149K | ﹤0.01% | 2200 |
|
|
2021
Q3 | $9.07M | Buy |
303,304
+6,289
| +2% | +$188K | ﹤0.01% | 2065 |
|
|
2021
Q2 | $13.2M | Buy |
297,015
+15,636
| +6% | +$693K | ﹤0.01% | 1856 |
|
|
2021
Q1 | $12.5M | Buy |
281,379
+20,843
| +8% | +$925K | ﹤0.01% | 1829 |
|
|
2020
Q4 | $14.3M | Buy |
260,536
+26,081
| +11% | +$1.43M | 0.01% | 1635 |
|
|
2020
Q3 | $5.36M | Buy |
234,455
+2,449
| +1% | +$56K | ﹤0.01% | 2027 |
|
|
2020
Q2 | $4.86M | Buy |
232,006
+23,454
| +11% | +$491K | ﹤0.01% | 2044 |
|
|
2020
Q1 | $2.91M | Buy |
208,552
+9,219
| +5% | +$129K | ﹤0.01% | 2102 |
|
|
2019
Q4 | $4.54M | Buy |
199,333
+11,346
| +6% | +$258K | ﹤0.01% | 2067 |
|
|
2019
Q3 | $2.19M | Buy |
187,987
+2,128
| +1% | +$24.8K | ﹤0.01% | 2344 |
|
|
2019
Q2 | $2.79M | Buy |
185,859
+39,917
| +27% | +$599K | ﹤0.01% | 2250 |
|
|
2019
Q1 | $2.56M | Buy |
145,942
+15,722
| +12% | +$276K | ﹤0.01% | 2275 |
|
|
2018
Q4 | $1.93M | Buy |
130,220
+6,020
| +5% | +$89.2K | ﹤0.01% | 2344 |
|
|
2018
Q3 | $3.06M | Buy |
124,200
+81,901
| +194% | +$2.02M | ﹤0.01% | 2276 |
|
|
2018
Q2 | $831K | Buy |
+42,299
| New | +$831K | ﹤0.01% | 2638 |
|
|
2017
Q2 | – | Sell |
-6,950
| Closed | -$56K | – | 3127 |
|
|
2017
Q1 | $56K | Hold |
6,950
| – | – | ﹤0.01% | 3036 |
|
|
2016
Q4 | $170K | Hold |
6,950
| – | – | ﹤0.01% | 2991 |
|
|
2016
Q3 | $264K | Hold |
6,950
| – | – | ﹤0.01% | 2826 |
|
|
2016
Q2 | $207K | Buy |
+6,950
| New | +$207K | ﹤0.01% | 2928 |
|